ITT Work in process increased by 42.6% to $178.50M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 45.8%, from $122.40M to $178.50M. Over 5 years (FY 2020 to FY 2025), Work in process shows an upward trend with a 10.1% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate production bottlenecks or scaling efforts, while a decrease suggests efficient throughput or reduced manufacturing activity.
Represents the value of goods that have entered the production process but are not yet finished. For a manufacturer like...
Peers in medical device manufacturing typically maintain lean WIP levels to optimize cash conversion cycles.
inv_work_in_progress| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $82.50M | $84.90M | $92.30M | $103.10M | $111.30M | $114.00M | $104.60M | $109.90M | $108.50M | $113.00M | $111.80M | $124.00M | $112.10M | $121.30M | $102.10M | $122.40M | $130.30M | $135.70M | $125.20M | $178.50M |
| QoQ Change | — | +2.9% | +8.7% | +11.7% | +8.0% | +2.4% | -8.2% | +5.1% | -1.3% | +4.1% | -1.1% | +10.9% | -9.6% | +8.2% | -15.8% | +19.9% | +6.5% | +4.1% | -7.7% | +42.6% |
| YoY Change | — | — | — | — | +34.9% | +34.3% | +13.3% | +6.6% | -2.5% | -0.9% | +6.9% | +12.8% | +3.3% | +7.3% | -8.7% | -1.3% | +16.2% | +11.9% | +22.6% | +45.8% |
| % of Inventories | 20.3% | 20.5% | 21.4% | 21.7% | 20.8% | 21.7% | 19.6% | 19.4% | 18.9% | 19.7% | 19.4% | 20.3% | 19.9% | 19.5% | 16.7% | 19.2% | 19.8% | 20.6% | 18.6% | 18.3% |
| Share Change | — | +0.2pp | +0.9pp | +0.3pp | -0.9pp | +0.9pp | -2.1pp | -0.2pp | -0.4pp | +0.7pp | -0.2pp | +0.9pp | -0.5pp | -0.3pp | -2.9pp | +2.5pp | +0.6pp | +0.8pp | -2.0pp | -0.4pp |